Bank Of New York Mellon Corp Omega Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.22 - $7.05 $73,942 - $123,530	17,522 New	17,522 $100,000
Q2 2022 Aug 15, 2022	SELL	$2.01 - $7.19 $111,106 - $397,441	-55,277 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$6.24 - $14.04 $249,188 - $560,673	39,934 Added 260.28%	55,277 $344,000
Q4 2021 Feb 11, 2022	BUY	$11.33 - $29.38 $27,248 - $70,658	2,405 Added 18.59%	15,343 $174,000
Q3 2021 Nov 12, 2021	BUY	$16.0 - $22.51 $207,008 - $291,234	12,938 New	12,938 $244,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $37.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.